HYTN anticipates the arrival of the initial cultivation batches for GMP processing in Q2 2025, with the first shipments to Germany expected in late Q2 2025. 1. Johnny Green, "Legal Medical Cannabis ...

Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...

Self-funded plans see preemption as a defense against state laws. A new primer for lawmakers suggests the rules could change.

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

The Philippine Economic Zone Authority (PEZA) said Friday that a new ecozone in Tarlac will host the country’s first ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

The global manufacturing execution systems market is expected to grow from USD 15.95 billion in 2025 to USD 25.78 billion in ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce ...